genentech, genentech,genentech

  1. 38 Posts.
    Since Lucentis cost much more than ILuvien, and Iluvien is as good or better in many cases I am told by medical professionals, then Genentech could enter bidding war for PSDV with Pfizer.This is in early bull phase of much bigger move and I added at $4.50. My humble opinion only
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.